Clinical Trial Update: An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis [Phase 4]

View source ↗

Summary

This document reports the completion of an open-label pharmacokinetic Phase 4 study of Naftin for tinea corporis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis

Drugs mentioned

• NAFTIN (NAFTIFINE HYDROCHLORIDE)

Snippet

Sponsor: Merz North America, Inc. | Conditions: Tinea Corporis | Phase 4 | Status: COMPLETED